Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Cardio-Oncology Corner

Progress documented, knowledge gaps identified at cardio-oncology workshop

Patrice Desvigne-Nickens, MD; Bishow Adhikari, PhD; Lori Minasian, MD, FACP; Nonniekaye Shelbourne, MS, CRNP, AOCN

Cover Story

Antithrombotic therapy after PCI in AF requires careful consideration

FDA News

FDA agrees to consider CV outcomes indication for alirocumab

FDA approves patisiran infusion for hereditary transthyretin-mediated amyloidosis

In Memoriam

In memoriam: Ronald G. Victor, MD

In memoriam: Joseph D. Babb, MD, MSCAI

In the Journals

AHA updates definition of resistant hypertension, addresses management in new scientific statement

Statins may not affect outcomes in older patients without diabetes, CVD

Panel favors PFO closure plus antiplatelet therapy for stroke prevention

Expert panel endorses genetic screening for FH

USPSTF: Evidence insufficient on benefits, risks of ECG to diagnose AF

HDL not as cardioprotective in postmenopausal women

Meeting News

Results mixed on rivaroxaban for extended thromboprophylaxis in MARINER

PURE: Moderate red meat, dairy intake may help reduce mortality, CV risk

No excess CV risk with lorcaserin for weight loss

MITRA-FR: MitraClip does not change prognosis in HFrEF, mitral regurgitation

VIDEO: New treatment option for rare cardiomyopathy may 'change lives'

COMMANDER HF: Low-dose rivaroxaban not effective in HF with sinus rhythm and CAD

ASCEND: Aspirin, omega-3 supplements fail for primary prevention in diabetes

ARRIVE: Aspirin does not reduce initial vascular events in low-to-moderate risk population

GLOBAL LEADERS: Long-term ticagrelor monotherapy not superior to standard DAPT

Pharmacology Consult

Do not go with the flow: Stemming the tide of GI bleeding with continuous-flow VADs

Audrey J. Littlefield, PharmD, BCPS, BCCP; Alana M. Ciolek, PharmD, BCPS

Trial Scorecards

Trial Scorecard: FREED

Trial Scorecard: MARINER

Trial Scorecard: COMMANDER-HF

Trial Scorecard: BASKET-SMALL 2

Trial Scorecard: POET

Trial Scorecard: ASCEND

Trial Scorecard: ARRIVE

Trial Scorecard: GLOBAL LEADERS